Distribution of angiographic measures of restenosis after drug-eluting stent implantation
暂无分享,去创建一个
A. Kastrati | J. Mehilli | A. Schömig | G. Ndrepepa | R. Iijima | R. Byrne | A. Dibra | S. Eberle
[1] A. Kastrati,et al. Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer. , 2009, JACC. Cardiovascular interventions.
[2] A. Kastrati,et al. Drug-Eluting Stents in Percutaneous Coronary Intervention , 2009, Drug safety.
[3] S. Pocock,et al. Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. , 2008, Journal of the American College of Cardiology.
[4] A. Kastrati,et al. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. , 2007, American heart journal.
[5] K. Kent,et al. Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents. , 2007, The American journal of cardiology.
[6] A. Colombo,et al. Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practice. , 2007, Journal of the American College of Cardiology.
[7] A. Colombo,et al. Angiographic analysis of pattern of late luminal loss in sirolimus- and paclitaxel-eluting stents. , 2007, The American journal of cardiology.
[8] AlbertSchömig,et al. Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents , 2006 .
[9] A. Kastrati,et al. Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents , 2006, Circulation.
[10] P. Serruys,et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. , 2006, JAMA.
[11] E. Orav,et al. Robustness of Late Lumen Loss in Discriminating Drug-Eluting Stents Across Variable Observational and Randomized Trials , 2005, Circulation.
[12] A Ralph Henderson,et al. The bootstrap: a technique for data-driven statistics. Using computer-intensive analyses to explore experimental data. , 2005, Clinica chimica acta; international journal of clinical chemistry.
[13] E. Orav,et al. Late Loss in Lumen Diameter and Binary Restenosis for Drug-Eluting Stent Comparison , 2005, Circulation.
[14] M. Krucoff,et al. Surrogates, substudies, and real clinical end points in trials of drug-eluting stents. , 2005, Journal of the American College of Cardiology.
[15] G. Breithardt,et al. Relationship of Late Loss in Lumen Diameter to Coronary Restenosis in Sirolimus-Eluting Stents , 2005, Circulation.
[16] A. Kastrati,et al. Interlesion dependence of the risk for restenosis in patients with coronary stent placement in in multiple lesions. , 1998, Circulation.
[17] A. Kastrati,et al. Bimodal distribution of angiographic measures of restenosis six months after coronary stent placement. , 1997, Circulation.
[18] M. Hadamitzky,et al. Predictive factors of restenosis after coronary stent placement. , 1997, Journal of the American College of Cardiology.
[19] P. Serruys,et al. Contributions of frequency distribution analysis to the understanding of coronary restenosis. A reappraisal of the gaussian curve. , 1996, Circulation.
[20] P. Serruys,et al. Patient, lesion, and procedural variables as risk factors for luminal re- narrowing after successful coronary angioplasty: A quantitative analysis in 653 patients with 778 lesions , 1993 .
[21] D. Baim,et al. Defining coronary restenosis. Newer clinical and angiographic paradigms. , 1993, Circulation.
[22] B. Rosner,et al. Lesion-to-lesion independence of restenosis after treatment by conventional angioplasty, stenting, or directional atherectomy. Validation of lesion-based restenosis analysis. , 1993, Circulation.
[23] J. Tijssen,et al. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and R , 1993, Journal of cardiovascular pharmacology.
[24] D. Baim,et al. Novel approach to the analysis of restenosis after the use of three new coronary devices. , 1992, Journal of the American College of Cardiology.
[25] P. Serruys,et al. Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution: a quantitative angiographic study in 1,445 successfully dilated lesions. , 1992, Journal of the American College of Cardiology.
[26] P. Serruys,et al. Relative Risk Analysis of Angiographic Predictors of Restenosis Within the Coronary Wallstent , 1991, Circulation.